Boldozon 250mg Horizon

£59.00

Boldozon 250mg Horizon contains boldenone undecylenate for advanced laboratory research into anabolic compound mechanisms. This pharmaceutical-grade research chemical enables detailed molecular studies of protein synthesis pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Boldozon 250mg Horizon
Boldozon 250mg Horizon
£59.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview: Boldozon 250mg Horizon

Boldozon 250mg Horizon is a research-grade anabolic steroid preparation containing boldenone undecylenate as its primary active compound. This laboratory specimen represents a sophisticated tool for investigating anabolic mechanisms at the cellular level. Manufactured by Horizon Pharmaceuticals to pharmaceutical standards, each vial delivers 250mg of precisely measured boldenone undecylenate for controlled experimental protocols. Research institutions studying protein synthesis pathways and anabolic signalling cascades frequently utilize this compound to examine molecular interactions within muscle tissue models. The preparation’s consistency makes it valuable for reproducible laboratory investigations across multiple research parameters.

Laboratory Research Applications

Scientists investigating anabolic compound mechanisms commonly examine Boldozon 250mg Horizon in controlled laboratory environments. Research applications include studying protein synthesis enhancement in cell culture models, investigating nitrogen retention mechanisms in tissue samples, and analyzing the compound’s interaction with androgen receptor pathways. The preparation enables researchers to evaluate anabolic effects on various cellular processes including collagen synthesis and erythropoiesis stimulation. Advanced laboratories studying performance enhancement compounds often compare this preparation against other anabolic agents to understand differential mechanisms of action. The compound’s long-acting undecylenate ester provides sustained research opportunities for extended observation periods.

Technical Specifications

Boldozon 250mg Horizon Research Specifications
Parameter Specification
Active Compound Boldenone Undecylenate
Concentration 250mg/ml
Manufacturer Horizon Pharmaceuticals
Form Injectable Solution
CAS Number 13103-34-9
Molecular Formula C30H44O3
Storage Room Temperature, Protected from Light

The compound’s molecular structure enables researchers at Stroid UK Shop to investigate various biochemical pathways related to anabolic processes. Laboratories studying boldenone compounds alongside other research chemicals like SARMs and peptides can examine comparative mechanisms of action across different compound classes.

Research Compliance Statement

Boldozon 250mg Horizon is supplied exclusively for in-vitro laboratory research purposes only. This product is not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate safety protocols and regulatory compliance when handling this research chemical.

Related